CHCHD2 P14L,在肌缩性侧面硬化症中发现,表现出细胞质错位并改变Ca2+平衡
Aya Ikeda1, Hongrui Meng2,3, Daisuke Taniguchi1
1Department of Neurology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo 113-8421, Japan.
PNAS nexus
|August 12, 2024
概括
与ALS相关的CHCHD2 P14L变体破坏了线粒体的处理,并导致TDP-43聚合. 这种致病变体会损害细胞平衡,导致神经退行性疾病机制.
科学领域:
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
- 遗传学 遗传学 是一个
背景情况:
- CHCHD2和CHCHD10是形成异构体的线粒体蛋白质,与帕金森病和ALS等神经退行性疾病有关.
- 这种CHCHD2 P14L变体与肌缩性侧面硬化症 (ALS) 有关.
研究的目的:
- 研究CHCHD2 P14L变异对线粒体功能和细胞平衡的影响.
- 确定CHCHD2 P14L是否是一种致病变体,有助于ALS病理生理学.
主要方法:
- 利用Drosophila模型来评估线粒体退化和CHCHD2变体的功能影响.
- 使用培养的人类神经母细胞SH-SY5Y细胞来分析动态和蛋白质聚合.
- 研究了在P14L变种存在的情况下CHCHD2和CHCHD10蛋白的局部化.
主要成果:
- 这种CHCHD2 P14L变异将CHCHD2从线粒体错位到细胞质中.
- 在多索菲拉神经元和人类SH-SY5Y细胞中CHCHD2 P14L表达减少了线粒体缓冲能力.
- CHCHD2 P14L诱导了细胞质升高,激活了calpain和caspase-3,导致TDP-43的处理和不溶性.
结论:
- 该CHCHD2 P14L变体是致病性,导致线粒体功能障碍和改变平衡.
- 由CHCHD2 P14L诱导的细胞变化,包括TDP-43聚合,反映了ALS病理生理学的关键方面.
- 这项研究强调了CHCHD2在ALS的背景下在维护线粒体完整性和细胞平衡方面的关键作用.
相关概念视频
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
03:03Amyloid Fibrils
9.4K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.4K
01:32Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K